Acadia Pharmaceuticals

Medical Science Liaison / Senior Medical Science Liaison

United States

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
BiopharmaceuticalsIndustries

Requirements

Candidates should possess an advanced science or clinical degree, such as an MD, DO, Pharm.D., PhD, NP, PA, or GC, and preferably have more than 5 years of experience as a Medical Science Liaison in a field-based role. Rare disease experience and a strong understanding of genetics are preferred, along with advanced computer skills including proficiency in MS Office applications.

Responsibilities

The Medical Science Liaison will establish and maintain relationships with thought leaders and healthcare professionals within the assigned territory, engaging in scientific exchange and serving as a scientific resource. They will support research initiatives, facilitate investigator-initiated research, deliver impactful presentations to diverse audiences, provide accurate assessments of community needs, and support company-sponsored research and publications while adhering to PhRMA guidelines and company SOPs. Additionally, the role involves staying abreast of scientific literature, supporting congress strategy, and potentially presenting clinical data at advisory boards.

Skills

Scientific exchange
Relationship building
Medical affairs
Scientific expertise
Research support
KOL engagement
Investigator liaison
Medical congress staffing
Advisory boards

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI